Skip to Content


“We are the center for groundbreaking discoveries in genomics that are saving lives and creating jobs along the way. Our innovation economy is driven by robust federal research funding through the National Institutes of Health. The discoveries of tomorrow and economic opportunities for the next generation depend on preserving this funding to keep San Diego at the forefront of innovation and discovery.”

Rep. Scott Peters, 52nd district of California
June 19, 2017

San Diego has provided fundamental genomic research that has galvanized scientific discovery across the globe. As we enter into an era of personalized medicine and technology, San Diego’s companies, research institutes, and universities will continue to pioneer discoveries across the interdisciplinary field of genomics. 
Genomics found its genesis in San Diego. San Diegan J. Craig Venter was the first to map the entire human genome in 2000 as part of a broad international science initiative. Venter’s multiple companies in the space, alongside the launch of sequencing company Illumina in 1998, set the stage for San Diego to become a trailblazer in the field. Dozens of companies, alongside a robust mix of public and private institutions such as the Salk Institute and Scripps Translational Science Institute now make up the local genomics ecosystem. With an influx of conferences such as the Festival of Genomics California moving events to San Diego and Illumina being repeatedly ranked as one of MIT Technology Review’s “50 Smartest Companies,” the region is well poised to continue to lead in this game-changing industry.1
Check out EDC's study, Cracking the Code: the Economic Impact of San Diego's Genomics Industry, and a timeline on the history of genomics.

Industry Highlights & Contributions

  • The impact: San Diego’s genomics industry directly supports more than 10,000 jobs found across more than 115 firms. In 2016, the industry’s gross regional product totaled $5.6 billion.2
  • Life-changing talent: In 2016, San Diego universities graduated more genomics talent than any other U.S. metro.2
  • Funding innovation: Despite representing only one percent of the U.S. population, San Diego attracted nearly 22 percent of venture capital investment in the genomics industry in 2016 - a sum of $292 million.2
  • #1 in patent intensity: From 2014-2016, San Diego was at the forefront of innovation, generating 371 genomics-related patents. Collectively, 28 firms in the region generated 120 genomics-related patents in 2016 alone.2

Key Companies 

  • Agena Bioscience
  • AltheaDx
  • Edico Genome
  • Helix
  • Human Longevity, Inc.
  • Illumina
  • Luna DNA
  • Pathway Genomics
  • Sequenom
  • Singlera Genomics
  • Synthetic Genomics
  • Thermo Fisher Scientific



1. MIT Technology Review, 2017, “50 Smartest Companies 2017” 2. San Diego Regional EDC, 2017, “Cracking the Code: The Economic Impact of San Diego’s Genomics Industry”